Strategy for the moments where healthcare systems lose time, money, and trust.

A3HCS (Advanced Healthcare Consulting Solutions) is a boutique physician-executive advisory practice founded by Nitesh Kumar, MD, MBA. It serves hospitals and health systems, hospice and home health agencies, life sciences companies, and digital health startups across operational diagnostics, compliance advisory, medical affairs, cyber risk, and clinical customer discovery. All engagements are flat fee, scoped in advance, and run directly by the founder. No junior associates, no staffed delivery teams.

A physician executive consultant reads clinical and financial data simultaneously, translating what the numbers say into the language a board, payer, or regulator will use to interpret the same data. At A3HCS, that means identifying the gap between your operational reality and how a reviewer reads it, then delivering a prioritized action sequence. The output is always an executive memo, not a slide deck.

Six active service lines: Hospital and Health System Operational Advisory, Hospice and HHA Diagnostic (CMS moratorium response), Healthcare Cyber Risk Advisory (HIPAA Security Rule), Life Sciences Medical Affairs Advisory (manuscripts, KOLs, CME), Health Tech Startup Clinical Customer Discovery, and Structured Healthcare Diagnostics. Each service line has flat-fee tiers published at a3hcs.org.

All fees are published and flat, no hourly billing. Diagnostic tiers are fixed: $2,500 for a 30-minute hospice/HHA diagnostic, $3,500 for a cyber risk snapshot, and $3,500 for a two-week DRG Impact Validation. Project-level engagements start at $5,000 for a 2-week hospital operational snapshot and $20,000 for a 6-8 week strategic advisory engagement. Retainers are quoted from a published floor that scales with organization size: $3,500+ per month for startup clinical advisory, $6,000+ for the fractional CAIO seat, $8,000+ for medical affairs, and $10,000+ for hospital and health system advisory. The floor is published, the scope is agreed in writing before you sign. No bait pricing, no scope creep.

Four primary buyer types: hospital and health system CEOs, COOs, and CMOs navigating operational, revenue cycle, or strategic pressure; hospice and home health agency owners facing CMS scrutiny or the May 2026 enrollment moratorium; pharma, medtech, and biotech medical affairs and regulatory teams; and pre-seed to Series A digital health and medtech founders who need clinical validation before building. Each buyer type has a dedicated service line.

Three differences. First, one physician executive runs every engagement, so the person who reads your data is the same person who delivers the memo and stands behind the recommendation. Large firms staff junior associates and have a partner sign off. Second, all A3HCS fees are flat and published, with no hourly billing and no open-ended scope. Third, the output is always an executive memo, not a multi-week PowerPoint process. You get the answer, not the deliverable that justifies the fee.

It means the clinical reasoning in your deliverable is reviewed by a physician before it reaches you. Every engagement is run and supervised by Nitesh Kumar, MD, MBA, so the operational recommendation and the clinical logic behind it are never separated and never handed to an analyst who can read only one of them. That is the supervision A3HCS provides: physician oversight of the advisory work itself. What it does not mean is care delivery. A3HCS advises organizations, not patients. No treatment decisions, no care delivery, no clinical supervision of your medical staff. Where a finding turns on a decision only your treating clinicians can make, the memo names the decision and routes it to them. Brain Revives, the patient and caregiver arm, is education infrastructure and not clinical care delivery.

Three hard boundaries. No clinical care: A3HCS advises organizations, not patients, and makes no treatment decisions. No legal or regulatory representation: A3HCS prepares you for a survey, an audit, or a board review, and does not represent you in one. Nothing in a memo is legal advice, and where a finding needs counsel, the memo says so and stops there. No reimbursement coding or billing: a diagnostic will find a coding or documentation gap and name it, because that is often where the margin is leaking, but correcting the gap and billing against it stays with your revenue cycle team or your coding vendor. Outside those three, scope is set at the diagnostic rather than assumed. If a finding points to work A3HCS is not the right party to run, the memo names the work and names who should do it.

Yes. Any engagement where protected health information is in scope runs under a signed BAA executed before the first data pull. The diagnostic is designed to work from aggregate and de-identified data wherever the finding does not require patient-level detail. Where patient-level review is necessary, as in a care coordination documentation audit, the scope, the sample size, and the handling terms are written into the engagement letter rather than negotiated afterward.

No. The diagnostic is a standalone, flat-fee engagement, and the executive memo is yours whether or not anything follows it. Some organizations take the memo to their board and execute internally, which is a legitimate outcome and often the right one. The diagnostic comes first in every engagement precisely so that neither party commits to execution before the problem is correctly named. There is no retainer conversion requirement and no auto-renewal.

Often yes, and usually as the second opinion rather than the replacement. A large firm is built to staff a workstream. A3HCS is built to tell you whether the workstream is aimed at the right thing. The Executive Advisory lane exists for exactly this: a strategic call your team, or your incumbent advisor, is too close to make. Engagements that run alongside an existing firm are scoped narrowly and in writing so there is no ambiguity about who owns which recommendation.

Yes. A3HCS works with healthcare organizations nationwide. Hospital and health system engagements are strongest in the Midwest, across Wisconsin, Illinois, Indiana, and Michigan, but are not limited by geography. The hospice and HHA diagnostic is specifically relevant to operators in the six CMS-named program integrity states (AZ, CA, NV, TX, OH, GA) but available nationwide. Life sciences and startup engagements are location-independent.

Submit the diagnostic request form at a3hcs.org. It takes under two minutes. The form routes to the founder directly, not to a sales team or auto-reply sequence. Expect a personal reply within two business days with a scoping call slot. If you know which service line fits, you can go directly to that page (Hospital, Hospice/HHA, Cyber, Life Sciences, Startups, or Diagnostics) and submit from there. All engagements start with a diagnostic before any execution work begins.

The diagnostic request form routes to the founder and gets a personal reply within two business days. A scoping call typically happens inside the following week, and a diagnostic can begin as soon as the engagement letter and, where applicable, the BAA are executed. Because one person runs every engagement, capacity is genuinely finite. If the calendar cannot accommodate the timeline you need, you will be told at the scoping call rather than after signing.